Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2022

03-05-2022 | Ulcerative Colitis | Editorial

Treating IBD? Don’t Forget that Mental Health Matters

Author: Edward L. Barnes

Published in: Digestive Diseases and Sciences | Issue 9/2022

Login to get access

Excerpt

In recent years, the impact of psychiatric disorders among patients with Crohn’s disease (CD) and ulcerative colitis (UC) has received increased attention due in large part to the disproportionate number of patients with inflammatory bowel disease (IBD) diagnosed with anxiety, depression, and other psychiatric comorbidities in comparison with the general population [1]. These psychiatric comorbidities not only affect an individual patient’s quality of life, these disorders have also been associated with a more severe disease course [2] and increased healthcare resource utilization [3, 4], which can negatively impact the healthcare system as well. …
Literature
1.
Bernstein CN, Hitchon CA, Walld R et al. increased burden of psychiatric disorders in inflammatory bowel disease. Inflamm Bowel Dis 2019;25:360–368.CrossRef
2.
Kochar B, Barnes EL, Long MD et al. Depression is associated with more aggressive inflammatory bowel disease. Am J Gastroenterol 2018;113:80–85.CrossRef
3.
Barnes EL, Kochar B, Long MD et al. Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database. Inflamm Bowel Dis 2017;23:875–881.CrossRef
4.
Szigethy EM, Allen JI, Reiss M et al. White paper AGA: the impact of mental and psychosocial factors on the care of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2017;15:986–997.CrossRef
5.
6.
Allegretti JR, Borges L, Lucci M et al. Risk factors for rehospitalization within 90 days in patients with inflammatory bowel disease. Inflamm Bowel Dis 2015;21:2583–2589.CrossRef
7.
Law CC, Sasidharan S, Rodrigues R et al. Impact of specialized inpatient IBD care on outcomes of IBD hospitalizations: a cohort study. Inflamm Bowel Dis 2016;22:2149–2157.CrossRef
8.
Liska D, Bora Cengiz T, Novello M et al. Do patients with inflammatory bowel disease benefit from an enhanced recovery pathway? Inflamm Bowel Dis 2020;26:476–483.CrossRef
9.
Regueiro M, Click B, Anderson A et al. Reduced unplanned care and disease activity and increased quality of life after patient enrollment in an inflammatory bowel disease medical home. Clin Gastroenterol Hepatol 2018;16:1777–1785.CrossRef
10.
Lores T, Goess C, Mikocka-Walus A et al. Integrated psychological care reduces health care costs at a hospital-based inflammatory bowel disease service. Clin Gastroenterol Hepatol 2021;19:96-103.e103.CrossRef
11.
Sowa NA, Jeng P, Bauer AM et al. Psychiatric case review and treatment intensification in collaborative care management for depression in primary care. Psychiatr Serv 2018;69:549–554.CrossRef
12.
Szigethy E, Murphy SM, Ehrlich OG et al. Mental health costs of inflammatory bowel diseases. Inflamm Bowel Dis 2021;27:40–48.CrossRef
13.
Long MD, Barnes EL, Herfarth HH, Drossman DA. Narcotic use for inflammatory bowel disease and risk factors during hospitalization. Inflamm Bowel Dis 2012;18:869–876.CrossRef
14.
Charilaou P, Mohapatra S, Joshi T et al. Opioid use disorder increases 30-day readmission risk in inflammatory bowel disease hospitalizations: a nationwide matched analysis. J Crohns Colitis 2020;14:636–645.CrossRef
Metadata
Title
Treating IBD? Don’t Forget that Mental Health Matters
Author
Edward L. Barnes
Publication date
03-05-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07510-y

Other articles of this Issue 9/2022

Digestive Diseases and Sciences 9/2022 Go to the issue

Original Article

Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population

Original Article

Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

Image of the Month

IgG4-Related Disease with Hypophysitis and Cholangitis as the Main Manifestations

Original Article

DNA Methylome Mapping Identifies Epigenetic Abnormalities in Intestinal Lymphocyte Regulation in Human Necrotizing Enterocolitis

Original Article

A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease

Original Article

A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits